The brand strength of Wiz Biotech was certified at the national level
Xiamen Wiz Biotech Co., Ltd has been awarded the Export Commodity Brand Certificate issued by the China Council for the Promotion of International Trade (CCPIT). This certificate helps Wiz to build international brand image, enhance brand influence and competitiveness, and develop overseas markets.
What is Certificate of Export Commodity Brand?
"Certificate of Export Commodity Brand " is a special service provided by CCPIT to actively cooperate with the national brand strategy. It can be described as "national endorsement" to verify and certify the export commodity brands of enterprises from eight dimensions, including R&D innovation ability, international certification, market recognition, intellectual property protection and global operation. Its legality and effectiveness have been accepted by governments, customs, chambers of commerce and enterprises in more than 200 countries and regions around the world, with wide overseas recognition. The certified enterprises and certified brands will be included in the "Export Commodity Brand Certification List" regularly issued by CCPIT, and will be sent to various Ministries and commissions of the State Council, business associations of various countries, diplomatic and consular missions in China, foreign representative offices and some high-end foreign-related events.
Wiz Biotech Product Catalogue sees below
Xiamen WIZ Biotech Co., LTD
Xiamen WIZ Biotech Co., LTD., founded in July 2013, is a state-level high-tech enterprise, a small giant enterprise of science and technology in Fujian Province, a specialized and special small and medium-sized enterprise, and an enterprise on the innovation layer of the New Third Board (securities code: 839355). As a high-tech company engaged in the research and development, production and sales of rapid diagnostic reagents and instruments, the company has always been committed to the tenet of "focusing on diagnostic technology and improving the quality of life" and focusing on technological innovation to develop POCT testing reagents and instruments, with a view to becoming a leader in the medical field of rapid diagnostic POCT. At present, the company has obtained more than 120 reagent menus at home and abroad, covering Helicobacter pylori detection, gastric cancer detection, pneumonia test, hormone test and other products. It has a platform for the development and preparation of antigen and antibody raw materials, as well as a mature immunochromatography technology platform, and focuses on the layout of microfluidic platform, molecular diagnosis platform, chemiluminescence platform and other platforms.
